Drug Profile


Alternative Names: Vanorm; WIN 42362; WY 42362

Latest Information Update: 22 Nov 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Wyeth
  • Class Class Ia antiarrhythmics; Class Ib antiarrhythmics; Class Ic antiarrhythmics; Phenylurea compounds; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Arrhythmias

Most Recent Events

  • 22 Nov 1999 No-Development-Reported for Arrhythmias in USA (IV)
  • 22 Nov 1999 No-Development-Reported for Arrhythmias in USA (PO)
  • 10 Aug 1995 A pharmacokinetic study has been added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top